Author

William G. Wierda

Observed names: W G Wierda, W WIERDA, W Wierda, W. G Wierda, W. G. Wierda, W. WIERDA, W. Wierda, W.G. Wierda, Wierda, W, Wierda, William G., William G Wierda, William George Wierda, William Wierda, William G. Wierda
Observed institutions: Northwestern University, University of Maryland, Baltimore, Roswell Park Comprehensive Cancer Center, National Institutes of Health, City Of Hope National Medical Center, Northwell Health, Georgia Institute of Technology, Cleveland Clinic, The Royal Melbourne Hospital, Hackensack University Medical Center, Seattle Cancer Care Alliance, Memorial Sloan Kettering Cancer Center, Karolinska University Hospital, The University of Texas MD Anderson Cancer Center, Texas State University, Harvard University, Emory University, The University of Melbourne, University of Pittsburgh, Duke University, Universität Ulm, Cornell University, University of Utah, Columbia University Irving Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Peter MacCallum Cancer Centre, Huntsman Cancer Institute, Nottingham City Hospital, University of Alabama at Birmingham, University of California San Diego, Massachusetts General Hospital, München Klinik Schwabing, Bristol-Myers Squibb (United States), Universitätsklinikum des Saarlandes, University of California, Irvine Medical Center, Cancer Research And Biostatistics, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, City of Hope, University Hospital Schleswig-Holstein, Dana-Farber Cancer Institute, BioCryst Pharmaceuticals (United States), Medical University of Lodz, Duke Medical Center, UPMC Hillman Cancer Center, Clinical Research Consortium, University of Utah Health Care, AstraZeneca (United States), University Hospital Cologne, University Hospital Ulm, Dana-Farber Brigham Cancer Center, Blood Cancer United, UCSF Helen Diller Family Comprehensive Cancer Center, Weill Cornell Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Herbert Irving Comprehensive Cancer Center, Moores Cancer Center, Duke Cancer Institute, Kite Pharma (United States), TG Therapeutics, Inc. (United States), Juno Therapeutics (United States), The Ohio State University, Sunesis (United States), Technische Universität Dresden, The University of Texas Health Science Center at Houston, University of Bologna, Stanford University
ORCID: 0000-0002-7357-270X
Observed ORCID: 0000-0002-7357-270X
OpenAlex ID: A5089428686
2017 · Sattva S. Neelapu, Sudhakar Tummala, et al. · Nature Reviews Clinical Oncology · 2,434
2013 · John C. Byrd, Richard R. Furman, et al. · New England Journal of Medicine · 2,265
2020 · Enli Liu, David Marin, et al. · New England Journal of Medicine · 2,211
2015 · Andrew W. Roberts, Matthew S. Davids, et al. · New England Journal of Medicine · 1,903
2015 · John C. Byrd, Bonnie Harrington, et al. · New England Journal of Medicine · 898
2016 · Stephan Stilgenbauer, Barbara Eichhorst, et al. · The Lancet Oncology · 805
2017 · Matthew S. Davids, Andrew W. Roberts, et al. · Journal of Clinical Oncology · 749
2010 · William G. Wierda, Thomas J. Kipps, et al. · Journal of Clinical Oncology · 590
2017 · Thomas J. Kipps, Freda K. Stevenson, et al. · Nature Reviews Disease Primers · 565
2005 · William Wierda, Susan O’Brien, et al. · Journal of Clinical Oncology · 524
2019 · Nitin Jain, Michael Keating, et al. · New England Journal of Medicine · 512
2016 · Partow Kebriaei, Harjeet Singh, et al. · Journal of Clinical Investigation · 502
Works count: 1,646
Citation count: 68,960
H-index: 127
I10-index: 640
Year
Topic
Type